On Monday, Shares of Duke Energy Corp (NYSE:DUK), gained 0.77% to $72.82. 2.30 million shares of the company were exchanged.
Duke Energy will release its third quarter 2015 earnings results at 7 a.m. ET on Thursday, Nov. 5.
An earnings conference call for analysts is planned for 10 a.m. ET that day to talk about Duke Energy’s financial performance for the quarter and provide other business and financial updates.
The conference call will be hosted by Lynn Good, president and chief executive officer, and Steve Young, executive vice president and chief financial officer.
Duke Energy Corporation, together with its auxiliaries, operates as an energy company in the United States and Latin America. It operates through three segments: Regulated Utilities, International Energy, and Commercial Power.
Shares of Sientra Inc (NASDAQ:SIEN), declined -12.55% to $6.13, during its last trading session.
Sientra, Inc. (SIEN), a medical aesthetics company, recently declared that it has sent a letter to plastic surgeons regarding products manufactured by Silimed, one of Sientra’s contract manufacturers.
Among other things, the letter updates plastic surgeons on actions Sientra is taking:
- Sientra has been in ongoing talk about with the United States Food and Drug Administration (FDA) regarding Brazilian regulatory inquiries into Silimed products, and is conducting its own review of the matter.
- Out of an abundance of caution, Sientra is voluntarily placing on temporary hold the sale in the United States of all Sientra devices manufactured by Silimed and also recommending that plastic surgeons discontinue implanting these devices until further notice.
- Brazilian and other regulatory agencies have reiterated that no reports of adverse events and no risks to patient health have been identified in connection with implanting Silimed-manufactured products, and, accordingly, there is no need to explant or adopt any specific procedure or action for those patients who have received them.
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; and breast tissue expanders.
Finally, Shares of Emerson Electric Co. (NYSE:EMR), ended its last trade with -0.42% loss, and closed at $46.95.
Addressing a growing industry demand for transformational improvements in capital project execution, Emerson recently launched Project Certainty, an innovative technology and engineering-based approach for improved capital efficiency and more reliable project plans.
Due to project excesses, billions of dollars are lost annually in oil and gas exploration and production, hydrocarbon and gas processing, chemical, pharmaceutical, and other process industries. According to industry data, over 65 percent of projects greater than $1 billion fail, with companies surpassing their budgets by more than 25 percent or missing plans by more than 50 percent. Routinely, they also face operational problems ongoing through the second year of operations. This comprising poor project performance can be a serious deterrent to process manufacturers considering new investments.
Emerson’s Project Certainty starts with early engagement during engineering and design studies to define project aims and high impact strategies to meet those aims. Despite traditionally accounting for about 4 percent of a project investment, automation is revealing unique and repeatable ways to eliminate cost, reduce complexity and accommodate late-stage project changes, beyond the automation discipline.
Emerson Electric Co. provides technology and engineering solutions to industrial, commercial, and consumer markets worldwide. It operates through five segments: Process Administration, Industrial Automation, Network Power, Climate Technologies, and Commercial & Residential Solutions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
